07:00 , Aug 29, 2011 |  BC Week In Review  |  Company News

Biomonitor, Thermo Fisher deal

Biomonitor granted Phadia AB rights to commercialize iLite technology for anti-drug antibody detection. The technology combines reporter gene assay technology with division-arrested, cryopreserved cells to measure an individual's immune response to drugs. Phadia develops and...
07:00 , Aug 23, 2010 |  BC Week In Review  |  Company News

Biomonitor A/S sales and marketing update

Biomonitor launched its iLite anti-Human IFN-beta 1a assay and iLite anti-Human IFN-beta 1b assay to detect neutralizing antibodies to interferon (IFN) beta 1a and 1b in Europe. The assays have CE Mark approval. Biomonitor also...